Analyst Speak:

“The Next Generation Sequencing Market is anticipated to reach US$ 12,756.4 Mn by 2025, and anticipated to grow prominent over seven years of forecast period 2019-2025 due to surge in prevalence of chronic diseases and increase in the demand for personalized medicine.”

Precision Business Insights (PBI) in its report titled “Next Generation Sequencing Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2014-2018 and Forecast 2019-2025” assesses the market performance over seven years forecast period from 2019 to 2025. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period.

Avail Sample Report of the Market @ https://www.precisionbusinessinsights.com/request-sample?product_id=15890

The next generation sequencing market anticipated to reach US$ 12,756.4 Mn by 2025. Rise in the prevalence of certain types of cancers and other chronic diseases due to change in daily life (For instance, As per World Health Organization 2018, around 9.6 Mn deaths occurred due to cancer), rise in demand for personalized medicine, development of advanced technologies for next generation sequencing, and rise in funding from public and private sectors for R&D are anticipated to bolster the next generation sequencing market over forecast years. However, high cost for the R&D, dearth of skilled professionals, complexity in the interpretation of data are hamper the growth of next generation sequencing market over the future years.

Next generation sequencing market segmented on the basis of product type, technology, application, end user, and region.

Consumables Segment Expected to Dominate the Market

Based on product type, the market is segmented into consumables, platforms, and services. Consumables segment dominated the global next generation sequencing market and expected to grow 9.6% CAGR over the forecast years owing to increase in the number of NGS procedures each year. Moreover, market players are focus on the R&D activities to launch newer NGS systems into market. For instance, in February 209, Agilent Technologies launched Magnis NGS Prep System, that contains reagents and protocols to assay multiple genes and complex genetic aberrations from genomic DNA including degraded samples such as formalin-fixed paraffin embedded (FFPE). In addition, services segment contributed a notable share in 2018 and the segment expected to grow at high CAGR over the forecast timeframe.

North-America, Accounts for Major Revenue Share for Next Generation Sequencing Market

Precision Business Insights (PBI), next generation sequencing market report analyses the market in different regions North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. Among all the regions, North America accounted for major revenue share due to surge in prevalence of cancer diseases in USA and Canada. For instance, according to National Cancer Institute 2018, approximately 1.7 Mn people diagnosed with cancer and 609,640 people will die from the disease. Additionally, surge in R&D for the development of novel techniques, presence of huge number of market players, and rise in demand for early stage disease diagnosis and personalized medicine are boost the market growth over the forecast years. Europe next generation sequencing market growing at significant growth rate attributed to adoption of advanced technologies, sophisticated healthcare infrastructure, and fundraising from public and private sectors are bolster the market over the forecast years.

Launch of Advanced technologies in Next Generation Sequencing Market

In October 2018, Qiagen N.V. launched QIAseq FastSelect RNA Removal Kit to target RNA types that are irrelevant to their research and remove them from RNA-seq libraries for next-generation sequencing

Key player’s profiles in the report are Agilent technologies, Inc., Qiagen N.V., Thermo Fisher Scientific, Inc., F. Hoffmann La Roche Ltd., Oxford Nanopore Technologies, Perkin Elmer, Inc., Pacific Biosciences of California, Inc., Eurofins Scientific, and bioMerieux SA.

For More Information @ https://www.precisionbusinessinsights.com/market-reports/global-next-generation-sequencing-market/

Detailed Segmentation

By Product Type

Consumables
Sample Preparation Consumables
Others
Platforms
MiSeq
HiSeq
SOLiD
Ion Torrent
Others
Services
Targeted Sequencing/Gene Panels
RNA-Seq
De Novo Sequencing
Exome Sequencing
Chip-Seq
Whole-Genome Sequencing
Methyl-Seq
Others

By Technology

Ion Semiconductor Sequencing
Sequencing by The Synthesis (SBS)
Nanopore Sequencing
Single-Molecule Real-Time (SMRT) Sequencing
Others

By Application

Drug Discovery
Diagnostics
Agriculture and Animal Research
Biomarker Discovery
Precision Medicine
Other Applications

By End-User Type

Biotechnology and Pharmaceutical Companies
Research Centers
Hospitals & Clinics
Others

Geography

North America

USA
Canada

Europe

Germany
France
UK
Italy
Spain
Russia
Poland
Rest of Europe

Asia-Pacific

Japan
China
India
Australia & New Zealand
ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
South Korea
Rest of Asia-Pacific

Latin America

Brazil
Mexico
Argentina
Rest of Latin America

Middle East and Africa (MEA)

Gulf Cooperation Council (GCC) Countries
Israel
South Africa
Rest of MEA

About Us:
 
Precision Business Insights is one of the leading market research and management consulting firm, run by a group of seasoned and highly dynamic market research professionals with a strong zeal to offer high-quality insights.
 
Contact Us:
 
Shreya Paul
Senior Business Development Executive
Email @ [email protected]
Call @ +1-866-598-1553
Precision Business Insights